Lorena Mardones

Dr. Lorena Mardones

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2021 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
Javad Sharifi-RadJavad Sharifi-Rad
Javad Sharifi-Rad
EQE. Cristina Quispe
E. Cristina Quispe
Monica BUTNARIUMonica BUTNARIU
Monica BUTNARIU
LRLia Sanda Rotariu
Lia Sanda Rotariu
Oksana SytarOksana Sytar
Oksana Sytar
Daniela CalinaDaniela Calina
Daniela Calina
The study describes the current state of knowledge on nanotechnology and its utilization in medicine. The focus in this manuscript was on the properties, usage safety, and potentially valuable applications of chitosan-based nanomaterials. Chitosan nanoparticles have high importance in nanomedicine, biomedical engineering, discovery and development of new drugs. The manuscript reviewed the new studies regarding the use of chitosan-based nanoparticles for creating new release systems with improved bioavailability, increased specificity and sensitivity, and reduced pharmacological toxicity of drugs. Nowadays, effective cancer treatment is a global problem, and recent advances in nanomedicine are of great importance. Special attention was put on the application of chitosan nanoparticles in developing new system for anticancer drug delivery. Pre-clinical and clinical studies support the use of chitosan-based nanoparticles in nanomedicine. This manuscript overviews the last progresses regarding the utilization, stability, and bioavailability of drug nanoencapsulation with chitosan and their safety.

26 November 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
MVMarcelo Villagran
Marcelo Villagran
JFJorge Ferreira
Jorge Ferreira
Miquel MartorellMiquel Martorell
Miquel Martorell
LMLorena Mardones
Lorena Mardones
Vitamin C is a water-soluble antioxidant associated with the prevention of the common cold and is also a cofactor of hydrolases that participate in the synthesis of collagen and catecholamines, and in the regulation of gene expression. In cancer, vitamin C is associated with prevention, progression, and treatment, due to its general properties or its role as a pro-oxidant at high concentration. This review explores the role of vitamin C in cancer clinical trials and the aspects to consider in future studies, such as plasmatic vitamin C and metabolite excretion recording, and metabolism and transport of vitamin C into cancer cells. The reviewed studies show that vitamin C intake from natural sources can prevent the development of pulmonary and breast cancer, and that vitamin C synergizes with gemcitabine and erlotinib in pancreatic cancer. In vitro assays reveal that vitamin C synergizes with DNA-methyl transferase inhibitors. However, vitamin C was not associated with cancer prevention in a Mendelian randomized study. In conclusion, the role of vitamin C in the prevention and treatment of cancer is still an ongoing area of research. It is necessary that new phase II and III clinical trials be performed to collect stronger evidence of the therapeutic role of vitamin C in cancer.

24 April 2019 in Journal of Physiology and Biochemistry
Verified
Journal Article
Closed access
PDF file
MVMarcelo Villagrán
Marcelo Villagrán
MMMirna Muñoz
Mirna Muñoz
EIEveling Inostroza
Eveling Inostroza
CVCamila Venegas
Camila Venegas
IRIván Ruminot
Iván Ruminot
LMLorena Mardones
Lorena Mardones

1 December 2019 in Revista chilena de nutrición
Verified
Journal Article
Open access
PDF file
MVMarcelo Villagrán
Marcelo Villagrán
MMMirna Muñoz
Mirna Muñoz
FDFredy Díaz
Fredy Díaz
CTClaudia Troncoso
Claudia Troncoso
CCCarlos Celis-Morales
Carlos Celis-Morales
LMLorena Mardones
Lorena Mardones
La vitamina C es uno de los antioxidantes más conocidos. Su ingesta ha sido asociada a un sinnúmero de beneficios, algunos de los cuales tienen un sustento científico débil o inexistente. En esta revisión se presentan en forma resumida aspectos biológicos que determinan la homeostasis de la vitamina C y se discute la información disponible sobre sus posibles efectos benéficos y su ingesta, en diversos países con especial énfasis en algunos grupos de riesgo. También se presentan sus efectos benéficos en inflamación, cáncer y enfermedades cardiovasculares, así como su acción de inmunomodulador y regulador epigenético. Se revisan también algunas fuentes dietarias de vitamina C y los factores que influyen en su estabilidad. Terminando con un análisis general de los trabajos relacionados con conducta de vida saludable en países latinoamericanos, que reflejan los malos hábitos alimentarios y que podrían dar cuenta de una hipovitaminosis de vitamina C aún no reportada y repercutir en el desarrollo de envejecimiento precoz y enfermedades crónicas no transmisibles.

1 November 2018 in Experimental Gerontology
Verified
Journal Article
Closed access
CTClaudia Troncoso-Pantoja
Claudia Troncoso-Pantoja
Fanny Petermann-RochaFanny Petermann-Rocha
Fanny Petermann-Rocha
RBRosemary Brown
Rosemary Brown
AOAna María Leiva Ordoñez
Ana María Leiva Ordoñez
MMMaría Adela Martinez
María Adela Martinez
Carlos Celis-MoralesCarlos Celis-Morales
Carlos Celis-Morales

5 January 2023 in Molecules
Verified
Journal Article
Open access
PDF file
MVMarcelo Villagrán
Marcelo Villagrán
CBCarlos Felipe Burgos
Carlos Felipe Burgos
CRCoralia I. Rivas
Coralia I. Rivas
LMLorena Mardones
Lorena Mardones
GLUT1 is a facilitative glucose transporter that can transport oxidized vitamin C (i.e., dehydroascorbic acid) and complements the action of reduced vitamin C transporters. To identify the residues involved in human GLUT1’s transport of dehydroascorbic acid, we performed docking studies in the 5 Å grid of the glucose-binding cavity of GLUT1. The interactions of the bicyclic hemiacetal form of dehydroascorbic acid with GLUT1 through hydrogen bonds with the -OH group of C3 and C5 were less favorable than the interactions with the sugars transported by GLUT1. The eight most relevant residues in such interactions (i.e., F26, Q161, I164, Q282, Y292, and W412) were mutated to alanine to perform functional studies for dehydroascorbic acid and the glucose analog, 2-deoxiglucose, in Xenopus laevis oocytes. All the mutants decreased the uptake of both substrates to less than 50%. The partial effect of the N317A mutant in transporting dehydroascorbic acid was associated with a 30% decrease in the Vmax compared to the wildtype GLUT1. The results show that both substrates share the eight residues studied in GLUT1, albeit with a differential contribution of N317. Our work, combining docking with functional studies, marks the first to identify structural determinants of oxidized vitamin C’s transport via GLUT1.